MediXall Group, Inc.
MDXL
$0.0039
$0.000411.43%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 34.18% | 32.14% | 33.19% | 28.76% | 29.36% |
| Total Depreciation and Amortization | -19.31% | -17.60% | -3.92% | 2,188.89% | 671.43% |
| Total Amortization of Deferred Charges | -61.97% | -20.37% | 62.95% | 298.49% | 3,764.41% |
| Total Other Non-Cash Items | -62.83% | -30.72% | -29.19% | 26.30% | -21.72% |
| Change in Net Operating Assets | 76.89% | 51.79% | 69.56% | -37.55% | -19.37% |
| Cash from Operations | 52.74% | 62.18% | 65.48% | 58.91% | 42.75% |
| Capital Expenditure | -- | -- | -- | -75.00% | -75.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 312.50% |
| Cash from Investing | -- | -- | -- | -275.00% | 117.65% |
| Total Debt Issued | -48.04% | -57.99% | -54.63% | -30.46% | 47.05% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -100.00% | -99.76% | -98.24% | -98.68% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -48.57% | -58.93% | -64.69% | -57.59% | -47.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 109.08% | 150.74% | 112.31% | 75.95% | -420.21% |